Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | BMEA |
---|---|---|
09:32 ET | 3378 | 11.63 |
09:34 ET | 530 | 11.51 |
09:36 ET | 2600 | 11.63 |
09:38 ET | 1900 | 11.56 |
09:39 ET | 444 | 11.59 |
09:41 ET | 18346 | 11.415 |
09:45 ET | 8078 | 11.3701 |
09:48 ET | 6762 | 11.4001 |
09:50 ET | 11353 | 11.44 |
09:52 ET | 3102 | 11.52 |
09:54 ET | 700 | 11.5499 |
09:56 ET | 400 | 11.5 |
09:57 ET | 1151 | 11.56 |
09:59 ET | 944 | 11.46 |
10:01 ET | 300 | 11.44 |
10:03 ET | 167 | 11.485 |
10:06 ET | 400 | 11.48 |
10:08 ET | 449 | 11.525 |
10:10 ET | 3172 | 11.46 |
10:12 ET | 200 | 11.46 |
10:14 ET | 4207 | 11.54 |
10:15 ET | 200 | 11.58 |
10:17 ET | 1393 | 11.58 |
10:21 ET | 400 | 11.56 |
10:24 ET | 300 | 11.61 |
10:26 ET | 846 | 11.57 |
10:28 ET | 1100 | 11.605 |
10:30 ET | 1358 | 11.63 |
10:32 ET | 1000 | 11.66 |
10:33 ET | 1629 | 11.65 |
10:35 ET | 2355 | 11.65 |
10:37 ET | 300 | 11.68 |
10:39 ET | 600 | 11.69 |
10:42 ET | 1500 | 11.66 |
10:44 ET | 1872 | 11.74 |
10:46 ET | 700 | 11.74 |
10:48 ET | 5900 | 11.72 |
10:50 ET | 500 | 11.7299 |
10:51 ET | 100 | 11.715 |
10:53 ET | 1406 | 11.72 |
10:55 ET | 450 | 11.74 |
10:57 ET | 100 | 11.72 |
11:00 ET | 2331 | 11.71 |
11:04 ET | 1983 | 11.66 |
11:06 ET | 566 | 11.64 |
11:08 ET | 100 | 11.645 |
11:09 ET | 1780 | 11.63 |
11:11 ET | 15049 | 11.79 |
11:13 ET | 300 | 11.81 |
11:15 ET | 1152 | 11.77 |
11:18 ET | 2571 | 11.75 |
11:20 ET | 900 | 11.74 |
11:22 ET | 1650 | 11.745 |
11:24 ET | 1005 | 11.74 |
11:26 ET | 600 | 11.72 |
11:27 ET | 1914 | 11.76 |
11:29 ET | 1516 | 11.75 |
11:31 ET | 5100 | 11.8 |
11:33 ET | 3319 | 11.83 |
11:36 ET | 4561 | 11.855 |
11:38 ET | 8702 | 11.81 |
11:40 ET | 4789 | 11.78 |
11:42 ET | 400 | 11.79 |
11:44 ET | 100 | 11.81 |
11:45 ET | 820 | 11.8 |
11:47 ET | 200 | 11.81 |
11:49 ET | 1250 | 11.845 |
11:51 ET | 15437 | 11.8375 |
11:54 ET | 4002 | 11.74 |
11:56 ET | 1966 | 11.73 |
11:58 ET | 200 | 11.745 |
12:00 ET | 400 | 11.74 |
12:02 ET | 4201 | 11.73 |
12:03 ET | 158 | 11.75 |
12:07 ET | 200 | 11.72 |
12:09 ET | 3608 | 11.75 |
12:14 ET | 632 | 11.785 |
12:16 ET | 100 | 11.76 |
12:18 ET | 654 | 11.8 |
12:20 ET | 100 | 11.81 |
12:21 ET | 960 | 11.78 |
12:23 ET | 1118 | 11.79 |
12:25 ET | 1001 | 11.715 |
12:27 ET | 105 | 11.71 |
12:30 ET | 1454 | 11.74 |
12:34 ET | 695 | 11.69 |
12:36 ET | 107 | 11.66 |
12:38 ET | 1137 | 11.645 |
12:39 ET | 200 | 11.6 |
12:43 ET | 1050 | 11.55 |
12:45 ET | 2472 | 11.61 |
12:48 ET | 730 | 11.6 |
12:50 ET | 100 | 11.57 |
12:52 ET | 436 | 11.555 |
12:54 ET | 1573 | 11.55 |
12:56 ET | 719 | 11.57 |
12:59 ET | 959 | 11.57 |
01:01 ET | 1239 | 11.6 |
01:03 ET | 431 | 11.64 |
01:08 ET | 1154 | 11.675 |
01:10 ET | 150 | 11.67 |
01:12 ET | 200 | 11.68 |
01:14 ET | 865 | 11.69 |
01:15 ET | 113 | 11.71 |
01:17 ET | 400 | 11.73 |
01:19 ET | 2606 | 11.755 |
01:21 ET | 300 | 11.79 |
01:24 ET | 300 | 11.77 |
01:26 ET | 1029 | 11.76 |
01:28 ET | 787 | 11.8 |
01:30 ET | 200 | 11.83 |
01:32 ET | 2256 | 11.825 |
01:33 ET | 1585 | 11.85 |
01:35 ET | 2234 | 11.765 |
01:37 ET | 241 | 11.74 |
01:39 ET | 350 | 11.71 |
01:42 ET | 1426 | 11.72 |
01:44 ET | 400 | 11.74 |
01:46 ET | 2233 | 11.74 |
01:48 ET | 200 | 11.76 |
01:50 ET | 200 | 11.76 |
01:51 ET | 400 | 11.73 |
01:53 ET | 300 | 11.72 |
01:55 ET | 1900 | 11.7287 |
01:57 ET | 423 | 11.745 |
02:00 ET | 300 | 11.76 |
02:02 ET | 1916 | 11.73 |
02:04 ET | 2477 | 11.7 |
02:06 ET | 300 | 11.74 |
02:08 ET | 345 | 11.755 |
02:09 ET | 200 | 11.75 |
02:11 ET | 1489 | 11.71 |
02:13 ET | 300 | 11.72 |
02:18 ET | 1328 | 11.71 |
02:20 ET | 560 | 11.74 |
02:22 ET | 600 | 11.67 |
02:24 ET | 800 | 11.69 |
02:26 ET | 100 | 11.675 |
02:27 ET | 300 | 11.66 |
02:29 ET | 2281 | 11.65 |
02:31 ET | 1226 | 11.66 |
02:33 ET | 250 | 11.655 |
02:36 ET | 663 | 11.65 |
02:38 ET | 949 | 11.6 |
02:40 ET | 315 | 11.58 |
02:42 ET | 800 | 11.6 |
02:44 ET | 400 | 11.56 |
02:45 ET | 732 | 11.58 |
02:47 ET | 1174 | 11.6 |
02:49 ET | 300 | 11.61 |
02:51 ET | 1062 | 11.6 |
02:54 ET | 100 | 11.605 |
02:56 ET | 250 | 11.6 |
02:58 ET | 1320 | 11.6375 |
03:00 ET | 800 | 11.68 |
03:02 ET | 450 | 11.6894 |
03:03 ET | 1916 | 11.6374 |
03:05 ET | 1500 | 11.63 |
03:07 ET | 300 | 11.6126 |
03:09 ET | 1950 | 11.6 |
03:12 ET | 300 | 11.61 |
03:14 ET | 400 | 11.62 |
03:16 ET | 814 | 11.63 |
03:18 ET | 700 | 11.61 |
03:20 ET | 1459 | 11.53 |
03:21 ET | 1035 | 11.569 |
03:23 ET | 473 | 11.55 |
03:25 ET | 500 | 11.52 |
03:27 ET | 1061 | 11.545 |
03:30 ET | 633 | 11.53 |
03:32 ET | 400 | 11.51 |
03:34 ET | 1100 | 11.54 |
03:36 ET | 1659 | 11.5 |
03:38 ET | 300 | 11.49 |
03:39 ET | 1185 | 11.45 |
03:41 ET | 1411 | 11.43 |
03:43 ET | 600 | 11.41 |
03:45 ET | 2995 | 11.43 |
03:48 ET | 5873 | 11.36 |
03:50 ET | 5327 | 11.375 |
03:52 ET | 17498 | 11.32 |
03:54 ET | 4013 | 11.3 |
03:56 ET | 10478 | 11.4 |
03:57 ET | 10448 | 11.47 |
03:59 ET | 158566 | 11.5 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Biomea Fusion Inc | 413.4M | -3.2x | --- |
Neurogene Inc | 420.6M | -7.1x | --- |
Terns Pharmaceuticals Inc | 383.5M | -4.7x | --- |
Anavex Life Sciences Corp | 380.9M | -9.1x | --- |
ACELYRIN Inc | 447.6M | -1.7x | --- |
Annexon Inc | 451.0M | -3.3x | --- |
Biomea Fusion, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of oral covalent small molecules to treat patients with metabolic diseases and genetically defined cancers. A covalent small molecule is a synthetic compound that forms a permanent bond to its target protein. The Company is utilizing its proprietary FUSION System to discover, design and develop a pipeline of covalent-binding small molecule medicines designed to maximize clinical benefit for patients. Its lead product candidate, BMF-219, is designed to be an oral, potent, and selective covalent inhibitor of menin, built from its FUSION System. It is developing BMF-219 for the treatment of menin regulated or dependent diseases, such as type 1 and type 2 diabetes as well as subtypes of liquid and solid tumors. Its second development candidate, BMF-500, a covalent inhibitor of activating mutations of the FMS-like tyrosine kinase 3 (FLT3).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $413.4M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 35.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-3.57 |
Book Value | $4.72 |
P/E Ratio | -3.2x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.